Biggest News Aggregation in the World
📰 Tech Therapeutics News

Tech Therapeutics News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Tech Therapeutics. Real-time updates on events, politics, business and more.

First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

SHANGHAI, Dec. 17, 2023 /PRNewswire/ — YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company’s first in vivo genome editing candidate being developed as a single dose, potentially curative therapy for hereditary transthyretin amyloidosis with cardiomyopathy (ATTR-CM). The study by YolTech is a single-arm, open-label, dose-escalation clinical trial (Clinicaltrials.gov: […]
Yuxuan Wu Yoltech Therapeutics Optimal Biologically Active Dose Transthyretin Protein Tech Therapeutics

First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company's first in vivo genome editing candidate being developed as a single dose, potentially curative therapy for hereditary transthyretin amyloidosis...
Yuxuan Wu Patient Dosed Clinical Trial Tech Therapeutics Optimal Biologically Active Dose Transthyretin Protein

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science